Infections with varicella zoster virus (VZV) are related to a variety of medical manifestations. Primary […]
Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine
Recurrent experiences of suboptimal influenza vaccine effectiveness have renewed calls to develop improved, broadly cross-protective […]
Green preparation of hydrogel particles-in-emulsions for simultaneous enhancement of humoral and cell-mediated immunity
Emulsions are one of essentially the most usually used vaccine adjuvant formulations. Although they promote […]
Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits
Immunotherapy to deal with most cancers is now a longtime scientific strategy. Immunotherapy may be […]
Improving the diagnosis of bovine tuberculosis using gold nanoparticles conjugated with purified protein derivative: special regard to staphylococcal protein A and streptococcal protein G
Different ancillary immunodiagnostic assessments had been traditionally-established for diagnosis of bovine tuberculosis (BTB) both mobile […]
Prediction and identification of CD4+ T cell epitope for the protective antigens of Mycobacterium tuberculosis
CD4+T cell epitopes performs a key position in anti-tuberculosis (TB) immunity, CD4+T cell epitopes appropriate for […]
West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
Introduction of West Nile (WN) virus into the United States in 1999 created main human […]